Liraglutide
Key Takeaways: Liraglutide
Liraglutide is a GLP-1 peptide primarily researched for:
- Significant blood sugar regulation
- High efficacy for weight loss
- Appetite suppression
Research Profile
Liraglutide (marketed as Victoza and Saxenda) is a GLP-1 receptor agonist that mimics the natural hormone responsible for regulating insulin and appetite.
Glycemic and Weight Control
Liraglutide works by slowing gastric emptying and signaling the brain’s satiety centers. Research has consistently shown it to be effective not only for managing Type 2 Diabetes but also for significant, sustained weight loss in obese subjects.
Long-Term Stability
Liraglutide is more stable than many other peptides. While it should be kept in the fridge prior to use, its formulated versions can survive at room temperature for up to 30 days, making it one of the more resilient compounds in the GLP-1 class.
Clinical Data & Studies
Key Benefits
- Significant blood sugar regulation
- High efficacy for weight loss
- Appetite suppression
- Cardiovascular protection
Potential Side Effects
- Nausea and vomiting
- Abdominal pain
Stability Profile
Stable for up to 6 weeks
Stable for 30 days (formulated)